Philip Lee
Chief Executive Officer at GeneFab LLC
Net worth: 261 262 $ as of 29/04/2024
Philip Lee active positions
| Companies | Position | Start | End |
|---|---|---|---|
GeneFab LLC
 GeneFab LLC BiotechnologyHealth Technology GeneFab LLC develops and commercializes genetic medicines. The American company was founded in 2023 and the CEO is Philip Lee. | Chief Executive Officer | 31/07/2023 | - |
Career history of Philip Lee
Former positions of Philip Lee
| Companies | Position | Start | End |
|---|---|---|---|
| SENTI BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 31/12/2020 | 06/08/2023 |
| Founder | 31/12/2015 | 06/08/2023 | |
| President | 31/12/2015 | 31/12/2017 | |
| Treasurer | 31/12/2015 | 31/12/2019 | |
| MERCK KGAA | Chief Tech/Sci/R&D Officer | 31/12/2011 | 31/10/2014 |
| Corporate Officer/Principal | 31/10/2014 | 30/04/2016 | |
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Chief Tech/Sci/R&D Officer | 31/12/2011 | 31/12/2013 |
| Corporate Officer/Principal | 31/12/2013 | 31/12/2015 | |
Cellasic Corp.
 Cellasic Corp. Packaged SoftwareTechnology Services Cellasic Corp. develops a microfluidic software platform for live cell analysis experiments. The American company was founded by Philip Lee. | Chief Executive Officer | 31/08/2004 | 31/03/2012 |
| Founder | 31/08/2004 | 31/03/2012 | |
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Director/Board Member | 30/06/2016 | 31/01/2018 |
| Chief Operating Officer | 31/01/2018 | 31/12/2020 | |
| Chief Tech/Sci/R&D Officer | 31/12/2020 | - | |
| Founder | 31/12/2015 | - | |
| President | 30/06/2016 | 31/01/2018 | |
| Treasurer | 31/01/2018 | 31/10/2020 |
Training of Philip Lee
| University of California, Berkeley | Doctorate Degree |
| The University of California, San Francisco | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistics
International
| United States | 9 |
| Germany | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
| President | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SENTI BIOSCIENCES, INC. | Health Technology |
| MERCK KGAA | Health Technology |
| Private companies | 4 |
|---|---|
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
Cellasic Corp.
Cellasic Corp. Packaged SoftwareTechnology Services Cellasic Corp. develops a microfluidic software platform for live cell analysis experiments. The American company was founded by Philip Lee. | Technology Services |
GeneFab LLC
GeneFab LLC BiotechnologyHealth Technology GeneFab LLC develops and commercializes genetic medicines. The American company was founded in 2023 and the CEO is Philip Lee. | Health Technology |
- Stock Market
- Insiders
- Philip Lee
- Experience
